ACE2 and COVID-19: Despite there is need to validate molecular mechanisms underlying this association, we hypothesized that the unbalance of ACE/ACE2 levels characterizing the D/D and I/D genotypes might induce apoptotic processes which target the endothelial cells of the vascular structure leading to coagulopathy and thus increased DD levels in COVID-19 patients.